7459 — Medipal Holdings Share Price
0.000.00%
Last trade - 00:00- ¥499bn
- ¥387bn
- ¥4tn
- 91
- 86
- 91
- 99
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 13.83 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -9.66% | ||
| Dividend Yield (f) | 2.72% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.79 | ||
| Price to Tang. Book | 0.85 | ||
| Price to Free Cashflow | 8.76 | ||
| Price to Sales | 0.14 | ||
| EV to EBITDA | 5.31 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.57% | ||
| Return on Equity | 8.2% | ||
| Operating Margin | 1.48% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 3,253,079 | 3,211,125 | 3,290,921 | 3,360,008 | 3,558,732 | 3,658,819 | 3,737,413 | 2.26% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -1.35 | +3.15 | -2.16 | +38.92 | -4.87 | -2.49 | -9.66 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
MEDIPAL HOLDINGS CORPORATION engages in the wholesale of pharmaceutical products, cosmetics and daily miscellaneous goods. The Company operates in three segments. The Ethical Pharmaceutical Wholesale segment is involved in the wholesale of pharmaceutical products, medical equipment and test reagents, the distribution and planning of specialty drugs, the construction of medical material database and others. The Cosmetics, Daily Product and General Medicine Wholesale segment is engaged in the wholesale of cosmetics, daily miscellaneous goods and general pharmaceuticals. The Veterinary Medicine and Food Processing Raw Materials Wholesale segment is engaged in the wholesale of veterinary products, food additives and food raw materials. The Company is also involved in the provision of cleaning services, the management and operation of logistics centers, the provision of manpower dispatching services and others.
Directors
- Shuichi Watanabe PRE (68)
- Kazuo Hashida FID
- Takuro Hasegawa CEX (65)
- Seiichi Kasutani CEX (58)
- Yasuhiro Chofuku VPR (66)
- Toshihide Yoda SMD (58)
- Yuji Sakon MDR (68)
- Hiroshi Yarimizu SME
- Kikuo Miki SEO
- Masaaki Shimizu SEO
- Hideaki Takemura SEO
- Yuji Taniguchi SEO
- Nobuhito Yanai DHR
- Kazuyoshi Kamata EXO
- Hisao Hiraga EXO
- Yoshitaka Ichiyanagi EXO
- Kazuki Kakutani EXO
- Shigeru Kanda EXO
- Sei Kashiwagi EXO
- Masanori Kawara EXO
- Teiji Kitahara EXO
- Yoichi Kuwajima EXO
- Mitsuhiro Kyogoku EXO
- Norikazu Matsui EXO
- Atsushi Takumiya EXO
- Teruhiro Yamazaki EXO
- Shinjiro Watanabe OTH (48)
- Koichi Mimura DRC (63)
- Toshio Asano IND (68)
- Hiroshi Iwamoto IND (62)
- Mitsuko Kagami IND (63)
- Kuniko Shoji IND (67)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 6th, 1923
- Public Since
- September 14th, 1995
- No. of Shareholders
- 9,821
- No. of Employees
- 13,075
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 207,950,318
- Address
- 3-1-1, Kyobashi, CHUO-KU, 104-0031
- Web
- https://www.medipal.co.jp/
- Phone
- +81 335175800
- Auditors
- KPMG AZSA LLC
Upcoming Events for 7459
Q1 2026 Medipal Holdings Corp Earnings Release
Similar to 7459
ASKA Pharmaceutical Holdings Co
Tokyo Stock Exchange
Astellas Pharma
Tokyo Stock Exchange
Astena Holdings Co
Tokyo Stock Exchange
CanBas Co
Tokyo Stock Exchange
CellSeed
Tokyo Stock Exchange
FAQ
What is the Medipal Holdings share price?
As of Today at 21:59 UTC, shares in Medipal Holdings are trading at ¥2,389. This share price information is delayed by 15 minutes.
How has the Medipal Holdings share price performed this year?
Shares in Medipal Holdings last closed at ¥2,389 and the price had moved by -1.02% over the past 365 days. In terms of relative price strength the Medipal Holdings share price has outperformed the Nikkei 225 Index by +4.31% over the past year.
What are the analyst and broker recommendations for Medipal Holdings?
The overall consensus recommendation for Medipal Holdings is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Medipal Holdings dividend yield?
The Medipal Holdings dividend yield is 2.51% based on the trailing twelve month period.
Does Medipal Holdings pay a dividend?
Last year, Medipal Holdings paid a total dividend of ¥60, and it currently has a trailing dividend yield of 2.51%.Looking ahead, the next dividend pay date is 2025-06-01.
When does Medipal Holdings next pay dividends?
We do not have data on when Medipal Holdings is to next pay dividends. The historic dividend yield on Medipal Holdings shares is currently 2.51%.
How do I buy Medipal Holdings shares?
To buy shares in Medipal Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Medipal Holdings?
As of the previous close price of ¥2,389, shares in Medipal Holdings had a market capitalisation of ¥499bn.
Where are Medipal Holdings shares listed?
Here are the trading details for Medipal Holdings:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 7459
What kind of share is Medipal Holdings?
Based on an overall assessment of its quality, value and momentum Medipal Holdings is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Medipal Holdings share price forecast for 2025?
The analyst consensus target price for shares in Medipal Holdings is ¥2,427. That is 1.61% above the last closing price of ¥2,389.
Analysts covering Medipal Holdings currently have a consensus Earnings Per Share (EPS) forecast of ¥191 for the next financial year.
Find out moreWhat is the trend in the Medipal Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medipal Holdings. Over the past six months, its share price has outperformed the Nikkei 225 Index by +6.38%.
As of the last closing price of ¥2,389, shares in Medipal Holdings were trading -1.73% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Medipal Holdings PE Ratio?
The Medipal Holdings PE ratio based on its reported earnings over the past 12 months is 13.83. The shares last closed at ¥2,389.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Medipal Holdings?
Medipal Holdings' management team is headed by:
- Shuichi Watanabe - PRE
- Kazuo Hashida - FID
- Takuro Hasegawa - CEX
- Seiichi Kasutani - CEX
- Yasuhiro Chofuku - VPR
- Toshihide Yoda - SMD
- Yuji Sakon - MDR
- Hiroshi Yarimizu - SME
- Kikuo Miki - SEO
- Masaaki Shimizu - SEO
- Hideaki Takemura - SEO
- Yuji Taniguchi - SEO
- Nobuhito Yanai - DHR
- Kazuyoshi Kamata - EXO
- Hisao Hiraga - EXO
- Yoshitaka Ichiyanagi - EXO
- Kazuki Kakutani - EXO
- Shigeru Kanda - EXO
- Sei Kashiwagi - EXO
- Masanori Kawara - EXO
- Teiji Kitahara - EXO
- Yoichi Kuwajima - EXO
- Mitsuhiro Kyogoku - EXO
- Norikazu Matsui - EXO
- Atsushi Takumiya - EXO
- Teruhiro Yamazaki - EXO
- Shinjiro Watanabe - OTH
- Koichi Mimura - DRC
- Toshio Asano - IND
- Hiroshi Iwamoto - IND
- Mitsuko Kagami - IND
- Kuniko Shoji - IND